We conclude that stromal CAF-secreted NRG-1 stimulates ErbB3/AKT signalling and promotes pancreatic cancer cell tumourigenesis, providing a mechanism that may contribute to PDAC resistance to anti-EGFR therapy. This evidence concerns the gene ERBB3 and familial pancreatic carcinoma.